ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2307건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2237 | Active, not recruiting | A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose. | Covid-19 Vaccine | Biological: PIKA COVID-19 vaccine Biological: Inactivated Covid-19 vaccine |
Phase 3 | Yisheng Biopharma (Singapore) Pte. Ltd. | INDUSTRY | 5860 | All | 18 Years | Health Index Multispecialty Clinic -Clinical Research, Cavite, Philippines Norzel Medical and Diagnostic Clinical, Cebu, Philippines Tropical Disease Foundation, Muntinlupa, Philippines St. John Hospital, Naga, Philippines UERM Research Center, Quezon City, Philippines Al Kuwait Hospital, Dubai, United Arab Emirates |
| 2236 | Unknown status | A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above | SARS-CoV-2 | Biological: SARS-CoV-2 mRNA Vaccine Biological: Placebo |
Phase 3 | Walvax Biotechnology Co., Ltd., Abogen Biosciences Co. Ltd., Yuxi Walvax Biotechnology Co., Ltd. | INDUSTRY | 28000 | All | 18 Years | Persahabatan Hospital, Jakarta, Indonesia Puskesmas Duren Sawit, Jakarta, Indonesia Puskesmas Kalideres, Jakarta, Indonesia Puskesmas Kebayoran Lama, Jakarta, Indonesia Puskesmas Pulogadung, Jakarta, Indonesia Centro de Investigacion Clinica del Pacifico S.A. de C.V. (CICPA), Acapulco, Mexico Centro de Investigacion y Avances Medicos Especializados (CIAME), Cancun, Mexico Centro de Especialidades Medicas Aplicadas, Mexico city, Mexico Instituto Nacional de Pediatria (INP), Mexico city, Mexico Oaxaca site management organization (OSMO), Oaxaca, Mexico Asociacion Mexicana para la investigacion clinica, A.C. (AMIC), Pachuca, Mexico Oncologico Potosino, San Luis Potosi, Mexico |
| 2235 | Unknown status | A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE | SARS-CoV Infection | Biological: Gam-COVID-Vac Other: placebo |
Phase 3 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, PDC-CRO | OTHER | 1000 | All | 18 Years | |
| 2234 | Completed | A Phase III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults. | SARS CoV 2 Infection | Biological: PHH1-V | Phase 3 | Hipra Scientific, S.L.U, Veristat, Inc., Asphalion, Fundacion FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promocion de la Salud y la Ciencia, Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta | INDUSTRY | 241 | All | 18 Years | Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain Hospital Clinic de Barcelona, Barcelona, Spain Hospital Josep Trueta, Girona, Spain Hacettepe University Medical Faculty Hospitals, Ankara, Turkey Ankara University Medical Faculty Hospitals, Ankara, Turkey Koc University Hospital, Istanbul, Turkey |
| 2233 | Unknown status | A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 | Safety and Efficacy | Biological: Recombinant new coronavirus vaccine (CHO cell) group Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group |
Phase 3 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | INDUSTRY | 28904 | All | 18 Years | Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China Biodimed Guayaquil Clinical Research Center, Guayaquil, Guayas, Ecuador Biodimed Alemania Clinical Research Center, Quito, Pichincha, Ecuador Biodimed Eloy Alfaro Clinical Research Center, Quito, Pichincha, Ecuador Fkui-Rscm, Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia FK Unpad/RSHS, Bandung, Jawa Barat, Indonesia Aziz Fatimah Hospital, Faisalabad, Punjab, Pakistan Avicenna Hospital, Lahore, Punjab, Pakistan Central Park Teaching Hospital, Lahore, Punjab, Pakistan National Hospital & Medical Center, Lahore, Punjab, Pakistan University of Health Sciences, Lahore, Punjab, Pakistan Al-Shifa Trust Eye Hospital, Rawalpindi, Punjab, Pakistan Indus Hospital and Health Network, Karachi, Sindh, Pakistan Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan Family Hospital No.15, Tashkent, Uzbekistan GUVD Poliklinika, Tashkent, Uzbekistan IIV Markaziy Poliklinika, Tashkent, Uzbekistan Toshkent viloyat IIV Poliklinika, Tashkent, Uzbekistan |
| 2232 | Recruiting | A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older | COVID-19 | Biological: EuCorVac-19 Biological: ChAdOx1 nCoV-19 |
Phase 3 | EuBiologics Co.,Ltd | INDUSTRY | 4000 | All | 18 Years | Trial site, Kinshasa, Congo, The Democratic Republic of the |
| 2231 | Active, not recruiting | A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults | COVID-19 | Biological: EuCorVac-19 Biological: ChAdOx1 nCoV-19 |
Phase 3 | EuBiologics Co.,Ltd | INDUSTRY | 2600 | All | 18 Years | Trial site, Manila, Philippines |
